Keyphrases
Electroconvulsive Therapy
100%
RNA Damage
65%
Psychological Stress
50%
DNA Damage
46%
Magnetic Resonance Imaging Study
40%
Sham Control
40%
Neural Response
40%
Functional Magnetic Resonance Imaging
40%
8-oxoGuo
33%
8-oxoguanine
32%
Oxidative Stress
29%
HPA Axis
26%
Hippocampus
23%
Corticosterone
22%
Schizophrenic Patients
22%
Childhood Adversity
20%
Family History of Depression
20%
Young Males
20%
Therapy Modification
20%
Cholesterol
20%
Psychiatric Illness
20%
Type 2 Diabetic Patients
20%
Seminal Plasma
20%
Psychopathology
20%
Asymmetric Dimethylarginine
20%
Emotional Faces
20%
DNA Repair Genes
20%
Cross-sectional Cohort Study
20%
Quality Parameters
20%
Blood-brain
20%
Neurotrophic Factors
20%
Registry-based
20%
Stimulus Intensity
20%
Healthy Individuals
20%
Human Seminal Plasma
20%
Autonomic Nervous System
20%
Immunohistochemical Investigation
20%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
20%
Subarachnoid Hemorrhage
20%
Single Session
20%
Childhood Trauma
20%
Stress Markers
20%
Dynamic Regulation
20%
Patients with Schizophrenia
20%
Adulthood
20%
Old Animals
20%
Sperm Count
20%
Atypical Antipsychotics
20%
Anesthesia
20%
Childhood Abuse
18%
Neuroscience
Electroconvulsive Therapy
75%
Psychological Stress
50%
Functional Magnetic Resonance Imaging
40%
Nerve Potential
40%
Oxidative Stress
35%
Nucleic Acid
34%
DNA Damage
30%
Hypothalamic-Pituitary-Adrenal Axis
28%
Corticosterone
25%
Glucocorticoid
22%
Positive Syndrome
21%
Neurotrophic Factor
20%
DNA Repair
20%
Atypical Antipsychotic
20%
Subarachnoid Hemorrhage
20%
Face
20%
Hippocampus
20%
6 N,n' Dimethylarginine
20%
Glucocorticoid Receptor
15%
Messenger RNA
15%
Medicine and Dentistry
Electroconvulsive Therapy
40%
DNA RNA Hybridization
21%
Case-Control Study
20%
Functional Magnetic Resonance Imaging
20%
Type 2 Diabetes
20%
Atypical Antipsychotic
20%
Nerve Potential
20%
Cohort Analysis
20%
Diabetes Mellitus
20%
Epileptic Seizure
20%
8-Oxo-2'-Deoxyguanosine
20%
N(g),n(g) Dimethylarginine
20%
Seminal Plasma
20%
Oxidative Stress
19%
